WebCerus Corporation is dedicated solely to safeguarding the world’s blood supply and aims to become the preeminent global blood products company. Headquartered in Concord, … WebDec 31, 2024 · Strong Revenue Growth Driven by Sales in North America Product Revenue of $44.0 Million Grew 10% YoY in the Fourth Quarter Reiterating Full-Year 2024 Product Revenue Guidance Range of $165-170 Million Cerus Corporation (Nasdaq: CERS) today announced financial results for the fourth quarter and full year ended December 31, …
Ipsos Healthcare: market research in the medical …
WebCerus.com The corporate website includes broad information about Cerus, resources for investors, and career opportunities. INTERCEPT-USA.com For residents of the United States – Blood centers and transfusion services will find topics related to the production of pathogen reduced products. HCP.INTERCEPT-USA.com WebCerus Corporation is dedicated solely to safeguarding the world’s blood supply and aims to become the preeminent global blood products company. Headquartered in Concord, California, the company develops and supplies vital technologies and pathogen-protected blood components to blood centers, hospitals, and ultimately patients who rely on safe ... pin joints
CERUS, Pleasure craft - Details and current position - MMSI …
WebApr 23, 2024 · Cerus Endovascular has received CE Mark approval for its Neqstent Coil Assisted Flow Diverter device designed for the treatment of intracranial aneurysms. Cerus Endovascular’s Neqstent is an adjunctive intrasaccular flow diverter device for the treatment of intracranial aneurysms. Credit: Jensflorian. WebJan 28, 2024 · On January 10, 2024, Cerus Corporation announced better than expected Q4 2024 revenues of $39.9 million, ending fiscal 2024 with $130.9 million in estimated total product revenues (up 42% from ... WebNov 1, 2024 · Extended Shelf Life Reflects Important Milestone toward Expanding Nationwide Footprint in Canada Cerus Corporation (Nasdaq:CERS) today announced it has received approval from Health Canada to extend the storage of platelets treated with the INTERCEPT Blood System from five days to seven days from the time of collection, … haaksirikkoisten patsas